BRIEF-Incyte and Calithera Biosciences announce global collaboration to develop and commercialize CB-1158
* Incyte and calithera biosciences announce global collaboration to develop and commercialize CB-1158, a first-in-class, small molecule arginase inhibitor [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: CB-1158, commercialize, develop, announce, inhibitor, arginase, molecule, small, a first-in-class, global collaboration, biosciences, calithera, Incyte, collaboration, global, Biosciences, Calithera, BRIEF-Incyte
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/fBAAW7Yi-0A/idUSFWN1FK0EU